Cargando…

Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis

Autoimmune hepatitis (AIH) is a rare disease of unclear etiology characterized by loss of self‐tolerance that can lead to liver injury, cirrhosis, and acute liver failure. First‐line treatment consists of systemic corticosteroids, or budesonide, and azathioprine, to which most patients are initially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrington, Claire, Krishnan, Swathi, Mack, Cara L., Cravedi, Paolo, Assis, David N., Levitsky, Josh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796683/ https://www.ncbi.nlm.nih.gov/pubmed/35611859 http://dx.doi.org/10.1002/hep.32591

Ejemplares similares

Noninvasive Prediction of Outcomes in Autoimmune Hepatitis–Related Cirrhosis
por: Llovet, Laura‐Patricia, et al.
Publicado: (2022)

Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic Steatosis
por: Chang, Jae Seung, et al.
Publicado: (2022)

Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients
por: Liu, Lingyan, et al.
Publicado: (2019)

Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope
por: Gala, Khushboo S., et al.
Publicado: (2020)

Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients
por: Yuan, Xiaoling, et al.
Publicado: (2019)

Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions
por: Czaja, Albert J.
Publicado: (2016)

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
por: Pearce, Steven G, et al.
Publicado: (2013)

Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson's Disease
por: Salaramoli, Sanaz, et al.
Publicado: (2023)

Autoimmune Hepatitis—Challenging Diagnosis
por: Mroskowiak, Aleksandra, et al.
Publicado: (2022)

Noninvasive biomarkers for lung cancer diagnosis, where do we stand?
por: Kammer, Michael N., et al.
Publicado: (2020)

Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives
por: Anastasiu, Costin Vlad, et al.
Publicado: (2020)

A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
por: Yang, Haiyan, et al.
Publicado: (2023)

Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis
por: Mazzara, Saveria, et al.
Publicado: (2015)

HLA Associations in pediatric autoimmune liver diseases: Current state and future research initiatives
por: Mack, Cara L.
Publicado: (2022)

Clinical management of autoimmune hepatitis
por: Pape, Simon, et al.
Publicado: (2019)

Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome
por: Nastasio, Silvia, et al.
Publicado: (2023)

Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives
por: Pellino, Gianluca, et al.
Publicado: (2018)

Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema
por: Wu, Kuo-An, et al.
Publicado: (2019)

NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension Diagnosis
por: Zha, Li-huang, et al.
Publicado: (2018)

Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis
por: Cheuk, Isabella Wai Yin, et al.
Publicado: (2017)

(23)Na‐MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis
por: Poku, Linda Osei, et al.
Publicado: (2020)

Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
por: Álvarez-Hilario, Lissuly Guadalupe, et al.
Publicado: (2023)

Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis
por: Bao, Suxia, et al.
Publicado: (2017)

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
por: Than, Nwe Ni, et al.
Publicado: (2019)

Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
por: Lai, N-s, et al.
Publicado: (2015)

Recent updates on the management of autoimmune hepatitis
por: Komori, Atsumasa
Publicado: (2021)

Accuracy of noninvasive methods for the diagnosis of liver fibrosis in children with chronic viral hepatitis
por: ElShahawy, A, et al.
Publicado: (2022)

Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern
por: Kado, Akira, et al.
Publicado: (2023)

Noninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down’s Syndrome
por: Liu, Xiangju, et al.
Publicado: (2017)

The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
por: Hernandez Roman, Jose, et al.
Publicado: (2020)

Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer
por: Han, Yueting, et al.
Publicado: (2021)

Autoimmune Hepatitis: A Review of Current Diagnosis and Treatment
por: Makol, Ashima, et al.
Publicado: (2011)

Diagnosis and Management of Autoimmune Hemolytic Anemias
por: Barcellini, Wilma, et al.
Publicado: (2022)

Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase
por: Zhan, Jie, et al.
Publicado: (2023)

Noninvasive diagnosis of hepatocellular carcinoma
por: Kim, Byung Seok
Publicado: (2012)

Scabies: Advances in Noninvasive Diagnosis
por: Micali, Giuseppe, et al.
Publicado: (2016)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B
por: Poynard, Thierry, et al.
Publicado: (2011)

Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?
por: Cantarelli, Chiara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pkkuhglhrpu23borbfq2484sd0